We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Open Source DNA: A New Way to Protect Privacy and Scientific Freedom in Genetic Research

By LabMedica International staff writers
Posted on 25 Sep 2009
Israeli and American scientists have devised a mathematical formula that can be used to protect genetic privacy while giving researchers much of the raw data they need to do pioneering medical research. More...


There exists a real fear spinning around today's genome research community that private genetic information could be used negatively against individuals. In 2008, after a published article found serious security holes in the way DNA data are made publicly available, health institutes in the United States and worldwide removed all genetic data from public access.

"Unfortunately, that knee-jerk response stymied potential breakthrough genetic research," says Dr. Eran Halperin of Tel Aviv University's Blavatnik School of Computer Sciences (Israel) and department of molecular microbiology and biotechnology. He wants to put this valuable DNA information back in circulation, and has developed the tool to do it-- safely.

Working with colleagues at the University of California in Berkeley (USA), Dr. Halperin devised the mathematical formula. Reported in the September 2009 issue of the journal Nature Genetics, the tool could keep millions of research dollars-worth of DNA information available to scientists. "We've developed a mathematical formula and a software solution that ensures that malicious eyes will have a very low chance to identify individuals in any study," commented Dr. Halperin, who is also affiliated with the International Computer Science Institute in Berkeley.

The mathematical formula that Dr. Halperin's team devised can determine which single nucleotide polymorphisms (SNPs, which are small pieces of DNA) that differ from individual to individual in the human population--are accessible to the public without revealing information about the participation of any individual in the study. Using computer software that implements the formula, the U.S. National Institutes of Health (NIH; Bethesda, MD, USA) and similar institutes worldwide can distribute important research data, but keep individual identities private. "We have been able to determine how much of the DNA information one can reveal without compromising a person's identity," said Dr. Halperin. "This means the substantial effort invested in collecting these data will not have been in vain."

Genome association studies can find links in the human genetic code for conditions such as autism and predispositions for cancer. Armed with this information, individuals can avoid environmental influences that might bring on disease, and scientists can develop new gene-based diagnosis and treatment tools.

Examining SNP positions in the genetic code, Dr. Halperin and his colleagues demonstrated the statistical improbabilities of identifying individuals even when their complete genetic sequence is known. "We showed that even when SNPs across the entire genome are collected from several thousand people, using our solution the ability to detect the presence of any given individual is extremely limited," he noted.

Dr. Halperin hopes his research will reverse the NIH policy, and he will provide access to the software so that researchers can use it to decide which genetic information can be safely loaded into a public database. He also hopes it will quash raging debates about DNA usage and privacy issues.

The Tel Aviv University-Berkeley research was conducted while Dr. Halperin was working with the International Computer Science Institute (ICSI), a nonprofit research institute with close relations to the University of California (UC) and Tel Aviv University.

Related Links:

Tel Aviv University's Blavatnik School of Computer Sciences
University of California in Berkeley
International Computer Science Institute



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.